An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: Human and macaque sequences, tissue distribution, unique and shared epitopes, and predictive autoantibodies

Molecular Medicine

Volumn 3, Issue 3, 1997, Pages 163-173

  LaGasse, James ^a   Jelinek, Laura ^b   Sexson, Shannon ^b   Lofton Day, Cathy ^b   Breininger, John ^a   Sheppard, Paul ^b   Kindsvogel, Wayne ^b   Hagopian, William A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ZYMOGENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; PROTEIN TYROSINE PHOSPHATASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; ENZYME ASSAY; ENZYME LOCALIZATION; HUMAN; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MACACA; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION;

EID: 0031000334     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401670     Document Type: Article

References (52)

1. Atkinson MA, Maclaren NK. (1994) The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331: 1428-1436.
2. Bottazzo GF, Florin-Christensen A, Doniach D. (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet ii: 1279-1283.
3. Marshall MO, Hxyer PE, Petersen JS, et al. (1994) Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies. J. Autoimmun. 7: 497-508.
4. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. (1995) Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the IDDM-related 37/40K autoantigen and a target of ICA. J. Immunol. 155: 5419-5426.
5. Hagopian W, Sanjeevi C, Kockum I, et al. (1995) Glutamate decarboxylase-, insulin-and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J. Clin. Invest. 95: 1505-1511.
6. Kolb H. (1994) Immune intervention in type I diabetes mellitus - current clinical and experimental approaches. Exp. Clin. Endocrinol. 102: 269-272.
7. Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL. (1990) Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J. Exp. Med. 172: 789-794.
8. Christie M, Hollands J, Brown T, Michelsen B, Delovitch T. (1993) Detection of pancreatic islet 64,000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J. Clin. Invest. 92: 240-248.
9. Christie MR, Genovese S, Cassidy D, et al. (1994) Antibodies to islet 37K antigen, but not glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43: 1254-1259.
10. Ongagna J-C, Levy-Marchal C. (1995) Anti-37K antibodies are associated with the development of IDDM in individuals with ICA. Diabetologia 38: 370-375.
11. Bingley P, Christie M, Bonifacio E, et al. (1994) Combined analysis of autoantibodies improves prediction of insulin-dependent diabetes in islet cell antibody-positive relatives. Diabetes 43: 1304-1310.
12. Bonifacio E, Genovese S, Braghi S, et al. (1995) Islet autoantibody markers in IDDM: Risk assessment strategies yielding high sensitivity. Diabetologia 38: 816-822.
13. Hagopian W, Karlsen A, Petersen J, et al. (1993) Regulation of glutamic acid decarboxylase (GAD) diabetes autoantigen expression in highly purified isolated islets from Macaca nemestrina. Endocrinology 132: 2674-2681.
14. Komori M, Kikuchi O, Sakuma T, et al. (1992) Molecular cloning of monkey liver cytochrome P-450 cDNAs: Similarity of primary sequences to human cytochromes P-450. Biochim. Biophys. Acta 1171: 141-146.
15. Jelinek L, Lok S, Rosenberg G, et al. (1993) Expression cloning and signaling properties of the rat glucagon receptor. Science 259: 1614-1616.
16. Rabin D, Pleasic S, Palmer-Crocker R, Shapiro J. (1992) Cloning and expression of IDDM-specific human autoantigens. Diabetes 41: 183-186.
17. Rabin D, Pleasic S, Shapiro J, et al. (1994) Islet cell antigen 512 is a IDDM-specific islet autoantigen related to protein tyrosine phosphatases. J. Immunol. 152: 3183-3188.
18. Lan M, Lu J, Goto Y, Notkins A. (1994) Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 13: 505-514.
19. Verge C, Gianani R, Kawasaki E, et al. (1996) Prediction of Type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA2 autoantibodies. Diabetes 45: 926-933.
20. Karlsen A, Hagopian W, Grubin C, et al. (1991) Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc. Natl. Acad. Sci. U.S.A. 88: 8337-8341.
21. Frohman M, Dush M, Martin G. (1988) Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. U.S.A. 85: 8998-9002.
22. Hagopian W, Karlsen A, Gottsäter A, et al. (1993) Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) shows 64K autoantibody positively at onset predicts diabetes type. J. Clin. Invest. 91: 368-374.
23. Dixon J. (1995) Structure and catalytic properties of protein tyrosine phosphatases. Ann. N.Y. Acad. Sci. 766: 18-22.
24. Chiang M-K, Flanagan J. (1996) PTP-NP, a new member of the receptor protein tyrosine phosphatase family, implicated in development of nervous system and pancreatic endocrine cells. Development 122: 2239-2250.
25. Brady-Kalnay S, Tonks N. (1995) Protein tyrosine phosphatases as adhesion receptors. Curr. Opin. Cell Biol. 7: 650-657.
26. Wasmeier C, Hutton J. (1996) Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J. Biol. Chem. 271: 8161-8170.
27. Lu J, Notkins A, Lan M. (1994) Isolation, sequence and expression of a novel mouse brain cDNA, mIA-2, and its relatedness to members of the protein tyrosine phosphatase family. Biochem. Biophys. Res. Commun. 204: 930-936.
28. 2-terminal domain. J. Cell Biol. 118: 309-320.
29. Aguilar-Diosdado M, Parkinson D, Corbett J, et al. (1994) Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes 43: 418-425.
30. Hartley S, Crosbie J, Brink R, Kantor A, Basten A, Goodnow C. (1991) Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353: 765-769.
31. Payton M, Hawkes C, Christie M. (1995) Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in IDDM to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest. 96: 1506-1511.
32. Lu J, Li Q, Xie H, et al. (1996) Identification of a second transmembrane protein tyrosine phosphatase, IA2β, as an autoantigen in insulin-dependent diabetes mellitus: Precursor of the 37kDA tryptic fragment. Proc. Natl. Acad. Sci. U.S.A. 93: 2307-2311.
33. Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E. (1996) Autoantibodies in IDDM recognize distinct cytoplasmic domains in the protein tyrosine phosphatase-like IA2 antigen. J. Immunol. 157: 2707-2711.
34. Palmer JP, Asplin CM, Clemons P, et al. (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337-1339.
35. Hummel M, Durinovic-Bello I, Zeigler A-G. (1996) Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes, J. Autoimmun. 9: 427-430.
36. Roep B. (1996) T-cell responses to autoantigens in IDDM. The search for the Holy Grail. Diabetes 45: 1147-1156.
37. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å. (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298: 167-169.
38. Atkinson M, Kaufman D, Campbell L, et al. (1992) Response of peripheral blood mononuclear cells to GAD in IDDM. Lancet 339: 458-459.
39. Arden S, Roep B, Neophytou P, et al. (1996) Imogen 38: A novel 38 kD islet mitochondrial autoantigen recognized by T-cells from a newly diagnosed type 1 diabetic patient. J. Clin. Invest. 97: 551-561.
40. Aanstoot H-J, Kang S-M, Kim J, et al. (1996) Identification and characterization of Glima 38, a glycosylated islet cell membrane antigen, which together with GAD65ab and IA2 marks the early phases of the autoimmune response in type I diabetes. J. Clin. Invest. 97: 2772-2800.
41. Atkinson M, Bowman M, Kao K, et al. (1993) Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N. Engl. J. Med. 329: 1853-1858.
42. Atkinson M, Holmes L, Scharp D, Lacy P, Maclaren N. (1991) No evidence for serological autoimmunity to islet cell heat shock proteins in insulin-dependent diabetes. J. Clin. Invest. 87: 721-724.
43. Thomas N, Ginsberg-Fellner F, McEvoy R. (1990) Strong association between diabetes and displacement of mouse anti-rat insulinoma cell monoclonal antibody by human serum in vitro. Diabetes 39: 1203-1211.
44. Karounas D, Odebunmi T, Hickman S, Stepiek-Biek P. (1992) Sequence determination of the diabetes-associated 52Kd autoantigen [abstract]. Diabetes 41: 97A.
45. Buschard K, Josefsen K, Rygaard J, Spitalnik S. (1991) Pancreatic islet-cell epitope recognized by an anti-sulphatide monoclonal antibody. APMIS 99: 1151-1156.
46. Dotta F, Dionisi S, Gianani R, et al. (1993) Expression of autoantibodies to the GM-2 islet ganglioside precedes the onset of type 1 diabetes in high risk subjects [abstract]. Diabetologia 36: A24.
47. Shimada A, Charlton B, Taylor-Edwards C, Fathman CG. (1996) β-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 45: 1063-1067.
48. Harris M, Robbins D. (1994) Prevalence of adult-onset IDDM in the U.S. population. Diabetes Care 17: 1337-1340.
49. Kobayashi T, Nakanishi K, Murase T, Kosaka K. (1996) Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in ICA-positive patients with clinical features of NIDDM. Diabetes 45: 622-626.
50. Björk E, Berne C, Kämpe O, Wibell L, Oskarsson P, Karlsson FA. (1996) Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. Diabetes 45: 1427-1430.
51. Fathman C. (1993) Peptides as therapy of autoimmune disease. Diabetes Metab. Rev. 9: 239-244.
52. Nag B, Mukku P, Arimilli S, Phan D, Deshpande S, Winkelhake J. (1994) Antigenic peptide binding to MHC class II molecules at increased peptide concentrations. Mol. Immunol. 31: 1161-1168.